Promoted Content

Promoted Content

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Mitotech

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Luxembourg

Post An Enquiry

Virtual Innovation Day

Participation Not Confirmed

Update your events

Mitotech and Essex Bio-Technology Complete Enrollment in VISTA-2 – a pivotal Phase 3 Clinical Study of SkQ1 for Dry Eye Disease

Contact the Supplier

Lead Product(s): Visomitin

Therapeutic Area: Ophthalmology Product Name: SkQ1

Highest Development Status: Phase III Product Type: Small molecule

Partner/Sponsor/Collaborator: Essex Bio

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 25, 2020

Details:

VISTA-2 is a multi-centre, randomized, double-blind, placebo-controlled clinical study involving two treatment arms: SkQ1 ophthalmic solution and vehicle solution, administered BID.